Document Type : Review Article

Author

School of Medicine, Shahid Beheshti University of Medical Sciences

Abstract

Gene therapy, as an experimental therapy, is applied for the treatment of diseases through modification of genes. Gene therapy corrects the mutated genes. Somatic and germline gene therapy are two main types of gene therapy. In germline editing, normal genes are inserted into the human’s eggs or sperm, zygote, or early embryo. Therefore, the gene is transmitted to the next generation, but in somatic gene therapy, a normal gene is inserted into somatic cells and corrects the defective gene without transmission to children. Personalized medicine is a novel therapeutic protocol for the prevention and treatment of diseases that considers individuals’ responding differences to medications.  So, it raises ethical issues. Ethical concerns regarding gene therapy and personalized medicine are as follows: safety, accessibility, cost-efficiency, genetic enhancement, dignity, autonomy, identity, and social discrimination.

Keywords

1.Worgall S, Crystal RG. Chapter 34 - Gene Therapy. In: Lanza R, Langer R, Vacanti J, editors. Principles of Tissue Engineering (Fourth Edition). Boston: Academic Press; 2014. p. 657-86.
2.Gonçalves GAR, Paiva RMA. Gene therapy: advances, challenges and perspectives. Einstein (Sao Paulo, Brazil). 2017;15(3):369-75.
3.Misra S. Human gene therapy: a brief overview of the genetic revolution. The Journal of the Association of Physicians of India. 2013;61(2):127-33.
4.Human Genome Editing: Science, Ethics, and Governance. Washington DC: 2017 by the National Academy of Sciences; 2017.
5.Delhove J, Osenk I, Prichard I, Donnelley M. Public Acceptability of Gene Therapy and Gene Editing for Human Use: A Systematic Review. Human gene therapy. 2020;31(1-2):20-46.
6.Dunbar CE, High KA, Joung JK, Kohn DB, Ozawa K, Sadelain M. Gene therapy comes of age. Science (New York, NY). 2018;359(6372).
7.Keeler A, ElMallah M, Flotte T. Gene Therapy 2017: Progress and Future Directions. Clinical and Translational Science. 2017;10(4):242-8.
8.Kumar SR, Markusic DM, Biswas M, High KA, Herzog RW. Clinical development of gene therapy: results and lessons from recent successes. Molecular therapy Methods & clinical development. 2016;3:16034.
9.Kumar A, Sharma P, Bhandari A. Gene Therapy: An Updated Review. European Journal of Biotechnology and Bioscience. 2014;1(3):42-53.
10.Goswami R, Subramanian G, Silayeva L, Newkirk I, Doctor D, Chawla K, et al. Gene Therapy Leaves a Vicious Cycle. Frontiers in oncology. 2019;9:297.
11.Zakrzewski W, Dobrzyński M, Szymonowicz M, Rybak Z. Stem cells: past, present, and future. Stem Cell Research & Therapy. 2019;10(1):68.
12.Alenzi F, Lotfy M, Tamimi W, Wyse R. Review: Stem Cells and Gene Therapy. Laboratory hematology : official publication of the International Society for Laboratory Hematology. 2010;16:53-73.
13.Biehl JK, Russell B. Introduction to stem cell therapy. J Cardiovasc Nurs. 2009;24(2):98-105.
14.Muñoz Ruiz M, Regueiro JR. New Tools in Regenerative Medicine: Gene Therapy. In: López-Larrea C, López-Vázquez A, Suárez-Álvarez B, editors. Stem Cell Transplantation. New York, NY: Springer US; 2012. p. 254-75.
15.Gaipov A, Myngbay A. Stem Cells Therapy in General Medicine. European Journal of General Medicine. 2018;15:50-3.
16.Resnik DB. Bioethics of Gene Therapy.  eLS(2012).
17.Deakin CT, Alexander IE, Kerridge I. Accepting risk in clinical research: is the gene therapy field becoming too risk-averse? Mol Ther. 2009;17(11):1842-8.
18.Kohn DB, Porteus MH, Scharenberg AM. Ethical and regulatory aspects of genome editing. Blood. 2016;127(21):2553-60.
19.McFarland TJ, Stout JT. CHAPTER 41 - Ocular gene therapy. In: Nguyen QD, Rodrigues EB, Farah ME, Mieler WF, editors. Retinal Pharmacotherapy. Edinburgh: W.B. Saunders; 2010. p. 285-91.
20.Greely HT. Ethical Issues in the ‘New’ Genetics. In: Smelser NJ, Baltes PB, editors. International Encyclopedia of the Social & Behavioral Sciences. Oxford: Pergamon; 2001. p. 4762-70.
21.Sade RM, Khushf G. Gene therapy: ethical and social issues. Journal of the South Carolina Medical Association (1975). 1998;94(9):406-10.
22.Thiele F. Bioethics: Examples from the Life Sciences. In: Smelser NJ, Baltes PB, editors. International Encyclopedia of the Social & Behavioral Sciences. Oxford: Pergamon; 2001. p. 1190-5.
23.Skorecki K, Galun E. 43 - Cell and Gene Therapy. In: Goldman L, Schafer AI, editors. Goldman’s Cecil Medicine (Twenty Fourth Edition). Philadelphia: W.B. Saunders; 2012. p. 203-11.
24.Verma IM. Germline Gene Therapy: Yes or No? Molecular Therapy. 2001;4(1):1.
25.Häyry M. Genetic Engineering of Human Beings. In: Chadwick R, editor. Encyclopedia of Applied Ethics (Second Edition). San Diego: Academic Press; 2012. p. 436-44.
26.Marshall D, Sharpe M, Ward S. Cell & gene therapies and the evolving role of personalized medicine. Cell and Gene Therapy Insights. 2016;2:277-86.
27.Swinney DC, Xia S. The discovery of medicines for rare diseases. Future Med Chem. 2014;6(9):987-1002.
28.Personalized medicine : legal and ethical challenges. 2020.
29.Noori-Daloii MR, Zafari N. The personalized medicine: today and tomorrow. MEDICAL SCIENCES JOURNAL. 2019;29(1):1-17.
30.Ventola CL. The role of pharmacogenomic biomarkers in predicting and improving drug response: part 2: challenges impeding clinical implementation. P t. 2013;38(10):624-7.
31.Schwab M, Schaeffeler E. Pharmacogenomics: a key component of personalized therapy. Genome Med. 2012;4(11):93.
32.Kiwanuka E, Hackl F, Nowinski D, Eriksson E. 15 - Molecular and gene therapies for wound repair. In: Farrar D, editor. Advanced Wound Repair Therapies: Woodhead Publishing; 2011. p. 395-415.
33.Macpherson I, Roqué MV, Segarra I. Ethical Challenges of Germline Genetic Enhancement. Frontiers in Genetics. 2019;10(767).
34.Khan SH. Genome-Editing Technologies: Concept, Pros, and Cons of Various Genome-Editing Techniques and Bioethical Concerns for Clinical Application. Molecular therapy Nucleic acids. 2019;16:326-34.
35.Kushner J. The ethics of personalized medicine. Personalized Medicine Universe. 2014;3:42-5.
36.Patil S, Al-Zoubi IA, Raghuram PH, Misra N, Yadav N, Alam M. Gene therapy: A comprehensive review. International Medical Journal. 2018;25:361-4.
37.Cordeiro JV. Ethical and legal challenges of personalized medicine: Paradigmatic examples of research, prevention, diagnosis and treatment. Revista Portuguesa de Saúde Pública. 2014;32(2):164-80.